Arvid M. Carlsson
Vorstandsvorsitzender bei A. Carlsson Research AB
Profil
Arvid Carlsson, M.D., Ph.D., has been a consultant to the Company since April 2002.
A co-recipient of the 2000 Nobel Prize for Medicine, Dr. Carlsson is currently Chief Executive Officer of Carlsson Research, a development stage neuroscience company that grew out of his research in the Department of Pharmacology at the University of Goteborg, Sweden.
Dr. Carlsson is Professor Emeritus at the University of Goteborg, and is a member of the Swedish Academy of Sciences and a foreign affiliate of the U.S.
National Academy of Sciences.
Dr. Carlsson has authored several hundred articles, which have helped to form the basis of modern neuropsychopharmacology.
In 1975, he was elected as a Foreign Corresponding Fellow of The American College of Neuropsychopharmacology.
In addition to the Nobel Prize, he has been the recipient of The Japan Prize in Psychology and Psychiatry, The Research Prize of the Lundbeck Foundation (Denmark) and the Lieber Prize (USA) for research in schizophrenia.
Dr. Carlsson's memberships include Member of the Academia Europaea, Member of the Royal Swedish Academy of Sciences, Honorary Fellow of the World Federation of Societies of Biological Psychiatry, Honorary Foreign Associate of the Institute of Medicine, National Academy of Sciences, U.S.A.
and Honorary Member of the German Society of Biological Psychiatry.
Dr. Carlsson received his M.D.
and Ph.D.
in Pharmacology from the University of Lund, Sweden.
Aktive Positionen von Arvid M. Carlsson
Unternehmen | Position | Beginn |
---|---|---|
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million. | Vorstandsvorsitzender | - |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Corporate Officer/Principal | - |
University of Gothenburg | Corporate Officer/Principal | 24.01.2011 |
Ehemalige bekannte Positionen von Arvid M. Carlsson
Unternehmen | Position | Ende |
---|---|---|
RESPIRERX PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Arvid M. Carlsson
University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million. | Health Technology |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Commercial Services |